MAP2K7 and lung carcinoma: In a recent study, ribonucleotide reductase might play a key role in suppressing the invasive capacity and anchorage‐independent growth of human lung cancers through the ability of the ribonucleotide reductase small subunit p53R2 to bind ERK kinase 2, thereby suppressing MEK‐ERK activity 19.